Used primarily in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds, particularly in the development of antipsychotic and antidepressant drugs. Its rigid tricyclic structure with a trifluoromethyl substituent enhances metabolic stability and binding selectivity to central nervous system receptors. This compound is also explored in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to modulate dopamine and serotonin pathways. Additionally, it serves as a building block in the design of novel heterocyclic systems for drug discovery.